As a result of various pharmacokinetic profiles, oral formulations will not be interchangeable with extended launch on an mg-mg foundation as a consequence of various pharmacokinetic profilesMight be provided as monotherapy or as adjunctive therapy with stimulants. The prolonged-release is not really interchangeable Using the rapid-launch product.H